(S (NP-SBJ (NP (DT A) (JJ novel) (NN SP-1) (NN site)) (PP (IN in) (NP (DT the) (JJ human) (NN interleukin-1) (NN beta) (NN promoter)))) (VP (VBZ confers) (NP (NP (JJ preferential) (JJ transcriptional) (NN activity)) (PP (IN in) (NP (NNS keratinocytes))))) (. .))
(S (S (NP-SBJ (-NONE- *-38)) (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (NNS mechanisms)) (PP (IN of) (NP (NP (JJ transcriptional) (NN activation)) (PP (IN of) (NP (NP (NN interleukin-1beta)) (PRN (-LRB- -LRB-) (NP (NN IL-1beta)) (-RRB- -RRB-)))) (PP (IN in) (NP (JJ non-monocytic) (NNS cells))))))))) (, ,) (NP-SBJ-38 (PRP we)) (VP-COOD (VP (VBD constructed) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NP (NN reporter) (NNS plasmids)) (PP (IN with) (NP (NP (DT the) (JJ bacterial) (NN chloramphenicol) (NN acetyltransferase) (NN gene)) (VP (VBN linked) (NP (-NONE- *)) (PP (TO to) (NP (NP (JJ various) (NNS parts)) (PP (IN of) (NP (DT the) (JJ human) (NN IL-1beta) (NN promoter)))))))))))) (CC and) (VP (VBD performed) (NP (JJ transient) (NN transfection) (NNS experiments)))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD identified) (NP (NP (DT a) (NN promoter) (NN segment)) (SBAR (WHNP-39 (WDT that)) (S (NP-SBJ (-NONE- *T*-39)) (VP (VBZ activates) (NP (NN transcription)) (ADVP (RBS most) (RB efficiently)) (PP (IN in) (NP (NNS keratinocytes)))))))) (. .))
(S (NP-SBJ (NP (NP (JJ Electrophoretic) (NN mobility) (NN shift) (NNS assays)) (PRN (-LRB- -LRB-) (NP (NN EMSA)) (-RRB- -RRB-))) (PP (IN with) (NP (NP (DT a) (ADJP (NN 43-mer)) (NN oligonucleotide)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (DT the) (ADJP (RB functionally) (VBN identified)) (JJ cis-acting) (NN element))))))) (VP (VBD revealed) (NP (JJ specific) (NNS complexes))) (. .))
(S (PP-COOD (PP (IN By) (NP-LGS (NP (NN competition) (NN analysis)) (PP (IN with) (NP (NN transcription) (NN factor) (NN consensus) (NN sequence) (NNS oligonucleotides))))) (CC and) (PP (IN by) (NP-LGS (NN immunosupershift)))) (, ,) (NP-SBJ-COOD-40 (NP (NN transcription) (NN factor) (NN SP-1)) (CC or) (NP (DT a) (ADJP (RB closely) (JJ related)) (NN protein))) (VP (VBD was) (VP (VBN shown) (S (NP-SBJ (-NONE- *-40)) (VP (TO to) (VP (VBP bind) (PP (TO to) (NP (DT this) (JJ regulatory) (NN element)))))))) (. .))
(S (NP-SBJ (NP (DT The) (JJS closest) (NN match)) (PP (TO to) (NP (DT the) (VBN known) (NN SP-1) (NN consensus) (NN sequence))) (PP (IN within) (NP (DT the) (JJ respective) (NN region)))) (VP (VBZ is) (NP-PRD (DT a) (NN TCCCCTCCCCT) (NN motif))) (. .))
(S (NP-SBJ (NP (NN Mutation)) (PP (IN of) (NP (DT this) (NN motif)))) (VP-COOD (VP (ADVP-COOD (ADVP (RB almost) (RB completely)) (, ,) (CC and) (ADVP (RB specifically)) (, ,)) (VBD abolished) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (CD two) (JJ low-mobility) (NNS complexes))))) (CC and) (VP (VBD led) (PP (TO to) (NP (NP (DT a) (CD 95) (NN %) (NN decrease)) (PP (IN of) (NP (NP (JJ constitutive) (JJ transcriptional) (NN activation)) (PP (IN of) (NP (NP (DT a) (NN reporter) (NN construct) (NN IL-1beta)) (PRN (-LRB- -LRB-) (NP (CD (+108 -170))) (-RRB- -RRB-)))))))))) (. .))
(S (ADVP (RB Likewise)) (, ,) (NP-SBJ (NP (NN activation)) (PP (IN of) (NP (DT this) (NN reporter) (NN construct))) (PP (IN by) (NP (NN tumor) (NN necrosis) (NN factor-alpha)))) (VP (VBD depended) (PP (IN on) (NP (DT the) (NN SP-1) (NN site)))) (. .))
(S (NP-SBJ (DT These) (NNS observations)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NP (DT a) (JJ so-far-unrecognized) (NN SP-1) (NN site)) (PP (IN in) (NP (DT the) (JJ human) (NN IL-1beta) (NN promoter)))) (VP (MD may) (VP (VB participate) (PP (IN in) (NP (NP (DT the) (JJ transcriptional) (NN regulation)) (PP (IN of) (NP (DT this) (NN gene))) (PP (IN in) (NP (NNS keratinocytes)))))))))) (. .))
